Meds, Mind, Body & Benefits > Research News & Studies

CROI 2013

(1/4) > >>

Jmarksto:
The Conference on Retroviruses and Opportunistic Infections (CROI) 2013 runs from March 3 - 6. 

Here is a link to the conference program, which includes the specific presentations. I haven't been around for the previous conferences, but this looks pretty comprehensive.

http://zika.retroconference.org/croi-2013-pocket-program.pdf

It should be a news worthy week.
JM

sensual1973:
we need something good this time.

YellowFever:
Sigh, the abstract titles do not look promising...

SB-728-T:
Central Memory T Cell Is the Critical Component for Sustained CD4 Reconstitution
in HIV Subjects Receiving ZFN CCR5 Modified CD4 T Cells (SB97289T)
"Not every patient's CD4 cells went up after our therapy but we think we know why"

"And don't ask us about Viral Load"

Tadeys:
Yellowfever, where did you get this information from?

 Did'nt Sangamo say Phase II info was going to be released later this year (meaning not in March, not at CROI)?

Been reading the threads from http://www.investorvillage.com/smbd.asp?mb=1933&mn=50615&pt=msg&mid=12562154 for the past 1/2 hour and can't find any info. Just speculation. Sangamo shares HAVE been going up these past few months...whatever that means( good or bad).

Jmarksto:
Tadeys;  Their Feb 14, 2013 Leerink Swann Global Healthcare Conference presentation on their website (you have to register, but they let me in)

http://investor.sangamo.com/events.cfm

Indicates that they will present prelim data the 1st half of 2013 (at CROI) for SB-728-902-5 and SB-728-1101, with complete data by the end of 2013. They also indicate they will be Phase 3 "ready" in 2013.

JM

Navigation

[0] Message Index

[#] Next page

Go to full version